retatrutide investigational drug triple hormone receptor agonist Medscape | Retatrutide, an that shows promise for weight loss in ongoing phase-3 clinical trials, is ADA 2026: Retatrutide Revolution
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
























